Four Days in Lille: Noventure at ESPGHAN 2026
Last week, Noventure took part in the 58th Annual Meeting of ESPGHAN in Lille, France, where our team presented the Tasectan® paediatric range to clinicians from across Europe and beyond.
Tasectan MDR Approved
GREAT NEWS! Noventure is delighted to announce that our medical device Tasectan has just been granted a new CЄ Certificate under MDR Regulation. With 3,7 Mio packs, equivalent to more than 51 Mio of standard units sold through our licensees in 34 countries during 2023, the Tasectan franchise is already [...]
New publication on the mode of action of Mucoprotectants: gelatin tannate and xyloglucan show similar effectivity on preventing Cholera Toxin-Induced diarrhea in experimental studies1
The newer antidiarrheal agents include the mucoprotectants gelatin tannate and xyloglucan. Both were able to attenuate cholera toxin-induced intra-loop water secretion in an experimental study in rats. This supports previous evidence that their mechanism of mucosal protection is closely related to their chemical structures, and involves the ability to form [...]
Gelatin tannate versus other antidiarrheal medication in children with acute gastroenteritis: a retrospective, observational study
Elena D Serban & Mihai Manolache; Journal of Comparative Effectiveness ResearchVol. 8, No. 3 Journal of Comparative Effectiveness ResearchVol. 8, No. 3 Publication of a retrospective, observational study on Gelatin tannate versus other antidiarrheal medication in children with acute gastroenteritis. Aim: To evaluate the effectiveness and safety of gelatin tannate [...]
Gelatin Tannate for Acute Childhood Gastroenteritis: A Randomized, Single-Blind Controlled Trial.
Maurizio Mennini1,Carlo Tolone, Antonella Frassanito, Fabio Midulla3, Salvatore Cucchiare, Marina Aloi. Paediatr Drugs. 2016 Dec 20. doi: 10.1007/s40272-016-0207-z Background: Oral rehydration therapy is the recommended treatment for acute childhood gastroenteritis. The aim of this study was to assess the efficacy and safety of gelatin tannate plus oral rehydration compared with [...]
“Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update”
Piqué N, Miñana-Galbis D, Machlab S. Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update. Ann Pediatr Child Health 2020; 8(6): 1194. Piqué N, Miñana-Galbis D, Machlab S. Advantages of Gel Oral Rehydration Solutions (ORS) for the Management of Acute Diarrhea: An Update. Ann [...]
Launch of TASECTAN® AF in Denmark
Noventure is glad to announce the launch of TASECTAN® AF in Denmark by its partner company Pharmaforce, thus setting a record time-to-market, after Noventure granted Pharmaforce exclusive distribution right for Tasectan® AF in the Nordic markets last April. Tasectan® AF is intended to restore the physiological functions of the intestinal [...]
TASECTAN® launched in Croatia by JGL
TASECTAN® launched in Croatia by JGL. Noventure is proud to announce the launch of TASECTAN® in Croatia by its partner company JGL, under the brand Normia Stop. TASECTAN® acts by forming a film which protects the intestinal mucosa, reducing the frequency and duration of diarrhea episodes in adults, children and [...]
Efficacy of gelatin tannate for acute diarrhea in children: a systematic review and meta-analysis.
Aloi M, Mennini M. J Comp Eff Res. 2018 Nov 22. Efficacy of gelatin tannate for acute diarrhea in children: a systematic review and meta-analysis. AIM: To investigate by meta-analysis the efficacy of gelatin tannate (GT), a mucosal barrier protector, in children with acute gastroenteritis. METHODS: A comprehensive literature search [...]
Noventure presents its pediatric range at the 51st ESPGHAN Annual Meeting in Geneva, 09-12 May 2018
As in previous years, Noventure has participated in the ESPGHAN Congress, held in Geneva, 09-12 May 2018. Pediatric gastroenterologists are a key target group for the recommendation and endorsement of new approaches to GI conditions in children. 4.627 delegates from 100 countries participated at the congress, and many of them [...]